Literature DB >> 33733653

Exploring the Seasonal Drivers of Varicella Zoster Virus Transmission and Reactivation.

Kevin M Bakker, Marisa C Eisenberg, Robert Woods, Micaela E Martinez.   

Abstract

Varicella zoster virus (VZV) is a herpesvirus that causes chickenpox and shingles. The biological mechanisms underpinning the multidecadal latency of VZV in the body and subsequent viral reactivation-which occurs in approximately 30% of individuals-are largely unknown. Because chickenpox and shingles are endemic worldwide, understanding the relationship between VZV transmission and reactivation is important for informing disease treatment and control. While chickenpox is a vaccine-preventable childhood disease with a rich legacy of research, shingles is not a notifiable disease in most countries. To date, population-level studies of shingles have had to rely on small-scale hospital or community-level data sets. Here, we examined chickenpox and shingles notifications from Thailand and found strong seasonal incidence in both diseases, with a 3-month lag between peak chickenpox transmission season and peak shingles reactivation. We tested and fitted 14 mathematical models examining the biological drivers of chickenpox and shingles over an 8-year period to estimate rates of VZV transmission, reactivation, and immunity-boosting, wherein reexposure to VZV boosts VZV-specific immunity to reinforce protection against shingles. The models suggested that the seasonal cycles of chickenpox and shingles have different underlying mechanisms, with ambient levels of ultraviolet radiation being correlated with shingles reactivation.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  herpesvirus; modeling; reactivation; varicella; varicella zoster virus; zoster

Mesh:

Year:  2021        PMID: 33733653      PMCID: PMC8579026          DOI: 10.1093/aje/kwab073

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   5.363


  32 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

2.  Recurrent outbreaks of measles, chickenpox and mumps. I. Seasonal variation in contact rates.

Authors:  W P London; J A Yorke
Journal:  Am J Epidemiol       Date:  1973-12       Impact factor: 4.897

3.  The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

Authors:  Hester de Melker; Guy Berbers; Susan Hahné; Hans Rümke; Susan van den Hof; Ardine de Wit; Hein Boot
Journal:  Vaccine       Date:  2006-02-24       Impact factor: 3.641

4.  Population-based study of herpes zoster and its sequelae.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

5.  Epidemiology of varicella zoster virus infection in Canada and the United Kingdom.

Authors:  M Brisson; W J Edmunds; B Law; N J Gay; R Walld; M Brownell; L L Roos; L Roos; G De Serres
Journal:  Epidemiol Infect       Date:  2001-10       Impact factor: 2.451

6.  Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.

Authors:  Monica Betta; Marco Laurino; Andrea Pugliese; Giorgio Guzzetta; Alberto Landi; Piero Manfredi
Journal:  Proc Biol Sci       Date:  2016-03-16       Impact factor: 5.349

7.  Global seasonality of rotavirus infections.

Authors:  S M Cook; R I Glass; C W LeBaron; M S Ho
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

8.  Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination.

Authors:  Napoleon Perez-Farinos; Luis Garcia-Comas; Rosa Ramirez-Fernandez; Juan-Carlos Sanz; Dolores Barranco; Cristina Garcia-Fernandez; Maria Ordobas
Journal:  Cent Eur J Public Health       Date:  2008-03       Impact factor: 1.163

9.  Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.

Authors:  Johannes Horn; Oliver Damm; Wolfgang Greiner; Hartmut Hengel; Mirjam E Kretzschmar; Anette Siedler; Bernhard Ultsch; Felix Weidemann; Ole Wichmann; André Karch; Rafael T Mikolajczyk
Journal:  BMC Med       Date:  2018-01-09       Impact factor: 8.775

10.  The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling.

Authors:  Derek A T Cummings; Sopon Iamsirithaworn; Justin T Lessler; Aidan McDermott; Rungnapa Prasanthong; Ananda Nisalak; Richard G Jarman; Donald S Burke; Robert V Gibbons
Journal:  PLoS Med       Date:  2009-09-01       Impact factor: 11.069

View more
  1 in total

1.  Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.

Authors:  Kevin M Bakker; Marisa C Eisenberg; Robert J Woods; Micaela E Martinez
Journal:  BMC Med       Date:  2022-10-08       Impact factor: 11.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.